Feedback PLC CCI Exclusive Distributor agreement with Boya
28 Juli 2017 - 11:53AM
RNS Non-Regulatory
TIDMFDBK
Feedback PLC
28 July 2017
28 July 2017
Feedback plc
("Feedback" or the "Company")
Exclusive distributor agreement with Boya Digital Technology
(Beijing) Co. Ltd
Feedback is pleased to announce that its subsidiary, Cambridge
Computed Imaging Ltd ("CCI"), has signed an exclusive distributor
agreement (the "Agreement") with Boya Digital Technology (Beijing)
Co. Ltd. ("Boya"), based in Beijing, China, for sales and
distribution of its TexRAD(R) texture analysis research software in
the People's Republic of China ("PRC"). Boya is an approved vendor
to GE Healthcare China, Beijing ("GE") and is facilitating the
purchase and installation process of TexRAD research software on
behalf of GE in the PRC.
TexRAD will be used by customers for research purposes,
performing advanced analysis of routinely acquired medical
diagnostic images (e.g. CT, MRI). As in western countries,
university hospitals and research institutions in China are
increasingly using innovative software such as TexRAD to generate
new knowledge and insights in the fight against cancer and other
diseases. The Agreement ensures user access and customer support
for TexRAD within the rapidly growing market for medical research
in the PRC.
Feedback regards the completion of this Agreement as a
significant step in the continuing development of its global sales
and market presence as outlined in recent investor
presentations.
Dr Balaji Ganeshan, CEO of TexRAD Ltd and Director of New
Business at Feedback Plc, said: "we are delighted to have
formalised the business relationship with both Boya and GE. This
follows discussions at the Beijing Society of Radiology in 2016 and
involvement in the installation of TexRAD software in a leading
medical institution, Peking Union Medical College Hospital,
Beijing. I look forward to working with Boya and GE to develop
awareness of the capabilities of TexRAD and sales to the medical
research community in China".
Ian McLellan, Commercial Director CCI Ltd, commented: "the
signing of this Agreement with Boya represents an excellent basis
on which to develop our sales and presence in this exciting growth
market using the expertise and customer reach of Boya Digital
Technologies. We look forward to developing the TexRAD revenue
potential and increasing the market reach to our users."
Ni Xiaowei, President of Boya Digital Technologies, stated: "we
are pleased with the addition of TexRAD to our software portfolio,
and look forward to working with CCI to promote this texture
analysis software to research institutes in leading hospitals
within the People's Republic of China. I anticipate a very
successful business relationship, working closely with Dr Balaji
Ganeshan and CCI. Boya Digital Technologies has developed a strong
reputation for IT sales and support with our customers which we can
offer to support the development of TexRAD sales in China."
For further information, please contact:
Feedback plc Tel: 01954 718072
Alastair Riddell
Allenby Capital Limited (Nominated Tel: 020 3328
Adviser and Joint Broker) 5656
David Worlidge / James Thomas
Northland Capital Partners Ltd (Joint Tel: 020 3861
Broker) 6625
Patrick Claridge / Margarita Mitropoulou
Peterhouse Corporate Finance Ltd Tel: 020 7469
(Joint Broker) 0936
Lucy Williams / Duncan Vasey
About CCI
CCI Ltd is owned by AIM listed Feedback Plc (FDBK), based in
Bourn, Cambridge UK. CCI focusses on the development and supply of
advanced software including TexRAD, for texture analysis of medical
images and storage and interpretation of imaging data.
About Boya
Boya Digital Technologies, founded in 2004 is based in Beijing,
China and has been a manufacturer and supplier of computers,
peripherals and software for over 10 years. It is a re-seller and
vendor to a number of companies in China. Boya is part of the
larger corporate organization, Boya Software Co Ltd, which aims to
create value for its customers through technology and services.
About TexRAD
TexRAD is a highly advanced, patented image texture analysis
software tool that analyses the textures in routinely acquired
diagnostic medical images (e.g. CT, MRI) to reveal features that
are not always evident to the human eye. The platform also
comprises a novel data-mining tool to assist the research customer
to undertake statistical analysis to identify interesting
parameters demonstrating association with patient outcome and
clinical parameters. A number of research studies published in
numerous peer-reviewed journals and conference presentations show
that TexRAD texture metrics may have the potential to predict
prognosis, disease severity and treatment prediction/evaluation in
a number of cancer applications. TexRAD is manufactured under
licence by the ISO 13485 certified company Cambridge Computed
Imaging Ltd, a subsidiary of Feedback plc.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAKMGZNLRGGNZG
(END) Dow Jones Newswires
July 28, 2017 05:53 ET (09:53 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024